Spire Healthcare Group PLC (LON:SPI) insider Gildersleeve,John purchased 57,300 shares of the company’s stock in a transaction that occurred on Wednesday, September 21st. The stock was acquired at an average cost of GBX 390 ($5.09) per share, with a total value of £223,470 ($291,698.21).

Shares of Spire Healthcare Group PLC (LON:SPI) opened at 388.50 on Thursday. The company’s market capitalization is GBX 1.55 billion. Spire Healthcare Group PLC has a 1-year low of GBX 275.00 and a 1-year high of GBX 411.00. The stock’s 50 day moving average is GBX 353.27 and its 200 day moving average is GBX 342.74.

The business also recently announced a dividend, which will be paid on Tuesday, December 13th. Investors of record on Thursday, November 17th will be issued a dividend of GBX 1.30 ($0.02) per share. This represents a dividend yield of 0.37%. The ex-dividend date is Thursday, November 17th.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/spire-healthcare-group-plc-spi-insider-gildersleevejohn-acquires-57300-shares.html

SPI has been the subject of several recent analyst reports. Barclays PLC reaffirmed an “overweight” rating and set a GBX 382 ($4.99) price objective on shares of Spire Healthcare Group PLC in a report on Friday, August 26th. Morgan Stanley reaffirmed an “equal weight” rating and set a GBX 340 ($4.44) price objective on shares of Spire Healthcare Group PLC in a report on Thursday, August 25th. Jefferies Group dropped their price objective on shares of Spire Healthcare Group PLC from GBX 360 ($4.70) to GBX 335 ($4.37) and set a “hold” rating for the company in a report on Tuesday, July 26th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 395 ($5.16) price objective on shares of Spire Healthcare Group PLC in a report on Wednesday, June 8th. Finally, Numis Securities Ltd reaffirmed an “add” rating and set a GBX 360 ($4.70) price objective on shares of Spire Healthcare Group PLC in a report on Thursday, August 25th. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Spire Healthcare Group PLC presently has a consensus rating of “Hold” and an average price target of GBX 372.50 ($4.86).

Spire Healthcare Group PLC Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.